Ledipasvir
Ledipasvir (GS-5885) is a small molecule NS5A inhibitor used in hepatitis C virus (HCV) research. It also acts as an inhibitor of the P-glycoprotein and Breast Cancer Resistance Protein (BCRP) transporters, making it a useful tool for in vitro and in vivo studies of drug efflux and pharmacokinetics.
Product Specifications
CAS Number
1256388-51-8
Product Name Alternative
SARSCoV, SARS coronavirus, SARS-CoV, Inhibitor, inhibit, Hepatitis C virus, HCV Protease, HCV, HCVProtease, Ledipasvir, GS 5885, GS5885, GS-5885, GT1a, GT1b
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
99.46% (May vary between batches)
Solubility
Ethanol:93 mg/mL (104.61 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (5.62 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ; DMSO:255 mg/mL (286.84 mM) ;2% DMSO+40% PEG300+5% Tween 80+53% Saline:1 mg/mL (1.12 mM)
Smiles
COC (=O) N[C@@H] (C (C) C) C (=O) N1CC2 (CC2) C[C@H]1c1ncc ([nH]1) -c1ccc2-c3ccc (cc3C (F) (F) c2c1) -c1ccc2nc ([nH]c2c1) [C@@H]1[C@H]2CC[C@H] (C2) N1C (=O) [C@@H] (NC (=O) OC) C (C) C
Molecular Formula
C49H54F2N8O6
Molecular Weight
889
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog